Catheter Precision Q1 2025: Minimal Revenue, Debt Obligations
Ticker: VTAK · Form: 10-Q · Filed: May 14, 2025 · CIK: 1716621
| Field | Detail |
|---|---|
| Company | Catheter Precision, Inc. (VTAK) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: 10-Q, medical-devices, early-stage, debt
TL;DR
Tiny revenue ($7k) for Catheter Precision in Q1 2025, lots of debt coming due.
AI Summary
Catheter Precision, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported minimal revenue, with $7,203 in revenue for the quarter. Total assets were $15,404, and total liabilities were $12,656, resulting in a small net loss. The company also disclosed various debt and warrant obligations with maturity dates extending up to July 2030.
Why It Matters
This filing indicates a company in its very early stages, with minimal revenue and significant future financial obligations, suggesting high risk for investors.
Risk Assessment
Risk Level: high — The company has extremely low revenue and significant future debt obligations, indicating a high risk of financial distress.
Key Numbers
- $7,203 — Revenue (Revenue for the quarter ending March 31, 2025, indicating minimal sales activity.)
- $15,404 — Total Assets (Total assets as of March 31, 2025, showing a very small asset base.)
- $12,656 — Total Liabilities (Total liabilities as of March 31, 2025, indicating a significant portion of assets are financed by debt.)
- 60,000,000 — Warrants Outstanding (A large number of warrants are outstanding, which could dilute future earnings per share.)
Key Players & Entities
- Catheter Precision, Inc. (company) — Filer of the 10-Q
- Ra Medical Systems, Inc. (company) — Former name of Catheter Precision, Inc.
- $7,203 (dollar_amount) — Revenue for the quarter ending March 31, 2025
- $15,404 (dollar_amount) — Total assets as of March 31, 2025
- $12,656 (dollar_amount) — Total liabilities as of March 31, 2025
- July 2030 (date) — Maturity date for a debt obligation
FAQ
What is the primary business of Catheter Precision, Inc.?
Catheter Precision, Inc. is in the business of Surgical & Medical Instruments & Apparatus, as indicated by its SIC code 3841.
What was the company's revenue for the first quarter of 2025?
The company reported $7,203 in revenue for the quarter ended March 31, 2025.
What are the company's total assets and liabilities as of March 31, 2025?
As of March 31, 2025, Catheter Precision, Inc. had total assets of $15,404 and total liabilities of $12,656.
When do the company's debt obligations mature?
The filing lists several debt and warrant maturity dates, with the latest being July 13, 2030, and September 3, 2029.
What was the company's former name?
The company was formerly known as Ra Medical Systems, Inc., with a name change effective September 8, 2017.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Catheter Precision, Inc. (VTAK).